IDXX Q4 2018 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q4 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$549M+8.5% YoY

Gross Profit

$300M54.7% margin

Operating Income

$115M21.0% margin

Net Income

$86M15.6% margin

EPS (Diluted)

$0.98

QoQ Revenue Growth

+0.7%

Cash Flow

Operating Cash Flow

$136M

Free Cash Flow

$96M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.5B

Stockholders' Equity

-$10M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$549M	$506M	+8.5%
Gross Profit	$300M	$272M	+10.2%
Operating Income	$115M	$98M	+17.9%
Net Income	$86M	$38M	+123.8%

Geographic Segments

UNITED STATES

$333M68%

Asia Pacific

$119M24%

CANADA

$23M5%

Latin America

$14M3%